Rash Associated with Dabigatran;Skin Necrosis Induced by Generic Enoxaparin;Serotonin Syndrome with Concomitant Use of Tapentadol and Venlafaxine;Etanercept-Induced Henoch-Schönlein Purpura;Vemurafenib-Associated Pancreatitis

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.